Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

YuanMing Capital

Investor type Private Equity Firm
Founders Fiona Gong Lawrence Tian Ming Jiang Tina Yu

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 12
Average round size
info
The average size of a deal this fund participated in
$84M
Portfolio companies 8
Rounds per year 2.00
Lead investments 3
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.33
Exits 1
Key employees 3
Stages of investment
Private Equity

Areas of investment

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Biopharma
  • Medical
Summary

The main office of represented VC is situated in the Haidian. The fund was located in Asia if to be more exact in China.

Among the various public portfolio startups of the fund, we may underline Ansun BioPharma, JW Therapeutics, CANbridge Life Sciences Among the most successful fund investment fields, there are Music, Health Care. The fund has exact preference in some founders of portfolio startups. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund.

The standard case for the fund is to invest in rounds with 5-6 partakers. Despite the YuanMing Capital, startups are often financed by Venrock, CHL Medical Partners, ProQuest Investments. The meaningful sponsors for the fund in investment in the same round are Oriza Seed Capital (Oriza Yuandian), WuXi AppTec, Matrix Partners China. In the next rounds fund is usually obtained by State Development & Investment Corporation (SDIC), RMB Funds, Qiming Venture Partners.

The fund was created by Fiona Gong, Lawrence Tian, Ming Jiang, Tina Yu. We also calculated 3 valuable employees in our database.

The high activity for fund was in 2018. The top amount of exits for fund were in 2010. This YuanMing Capital works on 19 percentage points less the average amount of lead investments comparing to the other organizations. The average startup value when the investment from YuanMing Capital is 100-500 millions dollars. The usual things for fund are deals in the range of 50 - 100 millions dollars. The real fund results show that this VC is 20 percentage points more often commits exit comparing to other companies. The fund is constantly included in less than 2 deals per year.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of YuanMing Capital:
Typical Co-investors
YuanMing Capital is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after YuanMing Capital:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from China
Funds with similar focus located in China:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Boquan Capital China, Hongkou District
Bull City Venture Partners North Carolina, Raleigh, United States
CITIC Industrial Investment Group -
Dawn Patrol Ventures California, Santa Monica, United States
DonBest California, Los Angeles, United States
Jishi Ronghui China, Futian, Guangdong
Mahindra finance India, Maharashtra, Mumbai
Necotium Barcelona, Catalonia, Spain
Pacific Venture Capital -
reinmkr capital California, Marina Del Rey, United States
Shi Shi Management Beijing, China, Fengtai
SME Support JAPAN -
Syntek Capital Bavaria, Bayern, Germany
TriTech Software Systems California, San Diego, United States
US Invest Arizona, Tempe, United States
ZZ Capital Beijing, Beijing, China

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

CF PharmTech

Health Care
Manufacturing
Pharmaceutical
$55M01 Jul 2020 Gusu District, Jiangsu, China

CANbridge Pharmaceuticals

Biotechnology
Health Care
Pharmaceutical
$98M18 Feb 2020 China, Beijing

Ascentage Pharma

Biopharma
Biotechnology
Medical
Pharmaceutical
$150M17 Jul 2018 China, Jiangsu

Adlai Nortye

Biotechnology
Health Care
$53M26 Jun 2018 Shangcheng District, Zhejiang, China

Mevion Medical Systems

Biotechnology
Health Care
Therapeutic Devices
Therapeutics
$150M14 Jun 2018 Massachusetts, United States

Ansun BioPharma

Biopharma
Biotechnology
Clinical Trials
Health Care
Medical
$85M14 May 2018 San Diego, California, United States

JW Therapeutics

Biotechnology
Health Care
Therapeutics
$90M07 Mar 2018 Shanghai, China

CANbridge Pharmaceuticals

Biotechnology
Health Care
Pharmaceutical
$25M23 May 2017 China, Beijing

Ascentage Pharma

Biopharma
Biotechnology
Medical
Pharmaceutical
$77M26 Dec 2016 China, Gusu District

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent YuanMing Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: